Article Text

Download PDFPDF
B16 Mitogen And Stress-activated Kinase-1 Deficiency And Transcriptional Dysregulation In Huntington’s Disease
  1. L Moumné1,2,3,
  2. K Brami-Cherrier4,
  3. S Betuing1,2,3,
  4. S Le Crom5,
  5. J Girault4,
  6. J Caboche1,2,3
  1. 1INSERM, UMR-S 1130, Neuroscience Paris Seine, F-75005, Paris, France
  2. 2CNRS, UMR 8246, Neuroscience Paris Seine, F-75005, Paris, France
  3. 3Sorbonne Universités, UPMC Université Paris 06, Neuroscience Paris Seine, F-75005, Paris, France
  4. 4Institut Du Fer À Moulin, UMR-S 839, Inserm and Université Pierre Et Marie Curie, 17 Rue Du Fer À Moulin, 75005 Paris, France
  5. 5École Normale Supérieure, Institut de Biologie de l’ENS, IBENS, Inserm, U1024, CNRS, UMR 8197, Paris


Transcriptional dysregulation has emerged as a pathogenic process that appears early in Huntington’s disease (HD) progression and has been recapitulated across multiple HD models. We have been studying the involvement of the Mitogen and Stress-activated Kinase-1 (MSK-1) in transcriptional dysregulation in HD. This striatum-enriched protein kinase acts on chromatin remodelling through histone H3 phosphorylation leading to transcriptional activation. MSK-1 plays a dual role in gene transcription since it also activates the transcription factor cAMP-responsive element binding protein (CREB) in the striatum. We have previously shown that MSK-1 expression is reduced in the striatum of HD patients and model mice. Its overexpression in primary striatal cells as well as in a rat model of HD prevents neuronal dysfunction and death induced by Exp-HTT. To understand the mechanism by which MSK-1 exerts its neuroprotective effect in the striatum it is important to identify its molecular targets. For this purpose we compared the expression of striatal genes between MSK-1 knock-out and wild type mice using a whole transcriptome shotgun sequencing. Among the genes dysregulated in MSK-1 KO mice, we identified genes involved in several cellular processes including oxidative or excitotoxic stress protection. Expression study of a set of these genes by quantitative RT-PCR showed that most of them are dysregulated in a cellular model (STHdh-Q111) and a mouse model (R6/2) of HD. These results suggest that MSK-1 down-regulation in HD is responsible for part of the transcription dysregulation observed in this disease and that restoring its expression could lead to reversion of these dysregulations.

  • MSK-1
  • Transcriptional dysregulation
  • chromatin remodelling
  • neuroprotection

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.